C-Reactive Protein, Fecal Calprotectin and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis

The value of fecal calprotectin as a marker of intestinal inflammation in patients with ulcerative colitis

(2016) Ibrahim Koral ONAL et al.   Turkish Journal of Gastroenterology

A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis

(2015) Maria Theresa Arias et al.   Clinical Gastroenterology and Hepatology

Serum C-reactive Protein and CRP Genotype in Pediatric Inflammatory Bowel Disease

(2015) Paul Henderson et al.   INFLAMMATORY BOWEL DISEASES

Mo1256 Role of Fecal Calprotection in Predicting Ileocolonic Endoscopic Recurrence in Postoperative Crohn's Disease

(2015) Christian Primas et al.   GASTROENTEROLOGY

How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis

(2014) Liseth Siemons et al.   BMC MUSCULOSKELETAL DISORDERS

Meta-analysis

(2014) Jin-Feng Lin et al.   INFLAMMATORY BOWEL DISEASES

Usefulness of a novel and rapid assay system for fecal calprotectin in pediatric patients with inflammatory bowel diseases

(2014) Keisuke Inoue et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies

(2013) Penny F. Whiting   ANNALS OF INTERNAL MEDICINE

FDG PET/CT in Crohn’s disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity

(2013) Babak Saboury et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Reply

(2013) William J. Sandborn et al.   GASTROENTEROLOGY

Reliability and Initial Validation of the Ulcerative Colitis Endoscopic Index of Severity

(2013) Simon P.L. Travis et al.   GASTROENTEROLOGY

A New Rapid Quantitative Test for Fecal Calprotectin Predicts Endoscopic Activity in Ulcerative Colitis

(2013) Triana Lobatón et al.   INFLAMMATORY BOWEL DISEASES

Fecal Calprotectin More Accurately Reflects Endoscopic Activity of Ulcerative Colitis than the Lichtiger Index, C-reactive Protein, Platelets, Hemoglobin, and Blood Leukocytes

(2013) Alain M. Schoepfer et al.   INFLAMMATORY BOWEL DISEASES

Neopterin Is a Novel Reliable Fecal Marker as Accurate as Calprotectin for Predicting Endoscopic Disease Activity in Patients with Inflammatory Bowel Diseases

(2013) Stephane Nancey et al.   INFLAMMATORY BOWEL DISEASES

P381 Role of fecal calprotection in predicting ileocolonic endoscopic recurrence in postoperative Crohn's disease

(2013) C. Primas et al.   Journal of Crohns & Colitis

A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease

(2013) Triana Lobatón et al.   Journal of Crohns & Colitis

Faecal calprotectin and lactoferrin as markers for monitoring disease activity and predicting clinical recurrence in patients with Crohn’s disease after ileocolonic resection: A prospective pilot study

(2013) Takayuki Yamamoto et al.   United European Gastroenterology Journal

Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study

(2012) Michael Manz et al.   BMC GASTROENTEROLOGY

Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Inflammatory Bowel Disease

(2012) Ingrid Ordás et al.   Clinical Gastroenterology and Hepatology

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

(2012) Geert DʼHaens et al.   INFLAMMATORY BOWEL DISEASES

Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease

(2012) Clas-Göran af Björkesten et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

(2011) Jean Frédéric Colombel et al.   GASTROENTEROLOGY

High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohnʼs disease: A marker for patient classification?

(2011) Lajos Sandor Kiss et al.   INFLAMMATORY BOWEL DISEASES

Correlation of C-Reactive Protein with Clinical and Endoscopic Activity in Patients with Ulcerative Colitis

(2010) Sami Karoui et al.   DIGESTIVE DISEASES AND SCIENCES

Fecal calprotectin is a predictive marker of relapse in Crohnʼs disease involving the colon: a prospective study

(2010) Lamia Kallel et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Endoscopic evaluation of Crohnʼs disease activity

(2010) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES

Crohnʼs disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection

(2010) Miguel Regueiro et al.   INFLAMMATORY BOWEL DISEASES

Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes and the CDAI

(2009) Alain M Schoepfer et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Clinical relevance of circulating midkine in ulcerative colitis

(2009) Malgorzata Krzystek-Korpacka et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Ulcerative colitis

(2009) Alain M. Schoepfer et al.   INFLAMMATORY BOWEL DISEASES

Fecal lactoferrin, myeloperoxidase and serum C-reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis

(2009) Ibrahim Masoodi et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

C-reactive protein across the menstrual cycle

(2008) Katherine Wander et al.   AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY

Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease

(2008) Jennifer Jones et al.   Clinical Gastroenterology and Hepatology

Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease

(2008) R. Berni Canani et al.   DIGESTIVE AND LIVER DISEASE

Small Intestine Peyer’s Patches Are Major Induction Sites of the Helicobacter-Induced Host Immune Responses

(2008) Norihiko Watanabe et al.   GASTROENTEROLOGY

S1266 Correlation Between C-Reactive Protein and b2-Microglobulin with Histologic Disease Activity in Ulcerative Colitis(UC)

(2008) Jesus A. Camacho-Escobedo et al.   GASTROENTEROLOGY

C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study

(2008) M Henriksen et al.   GUT

Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohnʼs disease

(2008) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES

C‐reactive protein and colorectal cancer risk: A systematic review of prospective studies

(2008) Konstantinos K. Tsilidis et al.   INTERNATIONAL JOURNAL OF CANCER

Meta-Analysis of Diagnostic Studies: A Comparison of Random Intercept, Normal-Normal, and Binomial-Normal Bivariate Summary ROC Approaches

(2008) Taye H. Hamza et al.   MEDICAL DECISION MAKING

Diagnostic yield of colonoscopy based on symptoms

(2008) Anders Lasson et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical Indices

(2007) Jost Langhorst et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY